5 Stocks Gaining Ground on Tuesday

2. Harpoon Therapeutics, Inc. (NASDAQ:HARP) has surged 14.83% as of 12:31 PM ET after the price target on the biotech company was raised from $14 to $18 by Zegbeh Jallah at Roth Capital. The analyst reiterated a Buy rating on Harpoon Therapeutics, Inc. (NASDAQ:HARP). Jallah revealed that Harpoon Therapeutics, Inc. (NASDAQ:HARP) is expanding its clinical programs while placing greater importance on DLL3 and BCMA.

As of Q4 2021, 14 hedge funds held a stake in Harpoon Therapeutics, Inc. (NASDAQ:HARP).